Insider: BELANOFF JOSEPH K Chief Executive Officer - CORCEPT THERAPEUTICS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,164,195 | 2,821,370 | 4,985,565 |
| Value | $180,850,955.18 | $235,767,784.05 | $416,618,739.23 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/02/2025 | DDS | 700 | Indirect | COM | $71.01 | $49,707.49 | 2,821,370 |
| 09/02/2025 | DDS | 39,300 | Indirect | COM | $70.52 | $2,771,325.96 | 2,822,070 |
| 08/01/2025 | DDS | 17,809 | Indirect | COM | $68.87 | $1,226,486.24 | 2,866,816 |
| 08/01/2025 | DDS | 16,745 | Indirect | COM | $67.81 | $1,135,416.49 | 2,884,625 |
| 08/01/2025 | DDS | 5,446 | Indirect | COM | $69.65 | $379,304.64 | 2,861,370 |
| 07/17/2025 | DDS | 615 | Indirect | COM | $73.69 | $45,317.69 | 2,901,370 |
| 06/02/2025 | DDS | 2,988 | Indirect | COM | $80.30 | $239,941.48 | 2,931,066 |
| 06/02/2025 | DDS | 1,820 | Indirect | COM | $81.33 | $148,012.41 | 2,929,246 |
| 06/02/2025 | DDS | 3,050 | Indirect | COM | $79.48 | $242,421.02 | 2,934,054 |
| 06/02/2025 | DDS | 4,881 | Indirect | COM | $78.42 | $382,773.39 | 2,937,104 |
| 06/02/2025 | DDS | 1,263 | Indirect | COM | $82.26 | $103,898.67 | 2,927,983 |
| 06/02/2025 | DDS | 12,959 | Indirect | COM | $84.57 | $1,095,962.07 | 2,910,393 |
| 06/02/2025 | DDS | 8,408 | Indirect | COM | $85.01 | $714,777.53 | 2,901,985 |
| 06/02/2025 | DDS | 4,631 | Indirect | COM | $83.46 | $386,523.17 | 2,923,352 |
| 05/02/2025 | DDS | 18,480 | Indirect | COM | $72.52 | $1,340,145.58 | 2,963,505 |
| 05/02/2025 | DDS | 21,520 | Indirect | COM | $73.22 | $1,575,776.18 | 2,941,985 |
| 04/01/2025 | DDS | 350 | Indirect | COM | $114.71 | $40,148.50 | 2,981,985 |
| 03/31/2025 | DDS | 35,102 | Indirect | COM | $94.72 | $3,324,861.44 | 2,982,335 |
| 03/24/2025 | DDS | 1,974 | Indirect | COM | $60.83 | $120,084.14 | 3,017,437 |
| 03/03/2025 | DDS | 2,924 | Indirect | COM | $60.91 | $178,097.92 | 3,019,411 |
| 07/07/2022 | DDS | 55,111 | Indirect | COM | $26.26 | $1,446,944.82 | 2,483,107 |
| 07/06/2022 | DDS | 279,908 | Indirect | COM | $26.27 | $7,352,007.55 | 2,538,218 |
| 12/12/2018 | DDS | 217,115 | Direct | COM | $19.01 | $4,126,509.40 | 2,164,195 |
| 11/11/2016 | DDS | 200,000 | Direct | COM | $9.10 | $1,820,300.00 | 2,164,195 |
| 11/10/2016 | DDS | 300,000 | Direct | COM | $8.90 | $2,670,450.00 | 2,164,195 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research